UNSPSC 51102839: Clioquinol/hydrocortisone/pramoxine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE250. This VA Drug Class (DE250) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL.

UNSPSC 51102839 Clioquinol/hydrocortisone/pramoxine is a Commodity code that classifies pharmaceutical products, though the recent state and local opportunities tagged under it reflect a broader pattern of government procurement for specialized pharmaceutical inventory rather than the specific topical combination named in the code. The work solicited includes warehouse supply agreements for pharmaceutical products and equipment supporting public health initiatives, procured through both traditional competitive bidding and piggyback cooperative purchasing arrangements. Issuing bodies have included state health departments and county governments pursuing pharmaceutical supply contracts and medical support systems for community health programs.

Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse supply contract through the MMCAP Infuse cooperative purchasing vehicle to Chartwell Rx LLC on August 28, 2026, for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets under an Invitation for Bid process, with a total contract value of $2,999,999.11 over 12 months plus two renewal option years. Seminole County, Florida released an IFB on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a two-year initial term and one-year renewal option. Recent activity appears concentrated in Florida and Illinois, with procurement driven by community health supply needs and public health agency inventory management.